Inventor · disambiguated record
Mahboubeh Kheirabadi
Also filed as: KHEIRABADI MAHBOUBEH
2 granted patents·10 pending applications·2 citations·filing 2018–2023
40Inventor score
Top patents by PatentIndex Score
12 records- 0177US11479581B2Non-chromatographic purification of macrocyclic peptides by a resin catch and releaseBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Oct 25, 2022·2 cites·7 claims
- 0273US12018097B2Non-chromatographic purification of macrocyclic peptides by a resin catch and releaseBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Jun 25, 2024·0 cites·2 claims
- 0366US2025011774A1Antisense compounds and methods for targeting cug repeatsENTRADA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0461US2024417429A1Compositions and methods for skipping exon 45 in duchenne muscular dystrophyENTRADA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0559US2025228953A1Intracellular targeting of oligonucleotidesENTRADA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0659US2024245790A1Cyclic cell penetrating peptidesENTRADA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0758US2023312653A1Cyclic cell penetrating peptidesENTRADA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0858US2025051393A1Compositions and methods for modulating interferon regulatory factor-5 (irf-5) activityENTRADA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0957US2024358845A1Compositions and methods for intracellular therapeuticsENTRADA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1054US2025243244A1Cyclic cell penetrating peptidesENTRADA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1149US2023020092A1Compositions for delivery of antisense compoundsENTRADA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1242US2023000960A1Neoantigen compositions and uses thereofBIONTECH US INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Mahboubeh Kheirabadi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →